T. Rowe Price Associates’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,339
| Closed | -$3.35M | – | 2519 |
|
|
2019
Q2 | $3.35M | Sell |
1,339
-341
| -20% | -$854K | ﹤0.01% | 1450 |
|
|
2019
Q1 | $6.85M | Sell |
1,680
-181
| -10% | -$738K | ﹤0.01% | 1364 |
|
|
2018
Q4 | $5.73M | Buy |
1,861
+381
| +26% | +$1.17M | ﹤0.01% | 1388 |
|
|
2018
Q3 | $8.65M | Buy |
1,480
+633
| +75% | +$3.7M | ﹤0.01% | 1398 |
|
|
2018
Q2 | $2.97M | Sell |
847
-1,261
| -60% | -$4.42M | ﹤0.01% | 1511 |
|
|
2018
Q1 | $9.37M | Sell |
2,108
-40
| -2% | -$178K | ﹤0.01% | 1344 |
|
|
2017
Q4 | $8.26M | Buy |
2,148
+191
| +10% | +$734K | ﹤0.01% | 1353 |
|
|
2017
Q3 | $9.14M | Buy |
1,957
+478
| +32% | +$2.23M | ﹤0.01% | 1333 |
|
|
2017
Q2 | $6.67M | Buy |
+1,479
| New | +$6.67M | ﹤0.01% | 1376 |
|